In a press release, the authors concluded: Tirzepatide consistently reduced body weight and waist circumference in people living with obesity or overweight with weight-related comorbidities regardless of the duration of disease
What the new clinical review says about GLP-1 facial changes On July 22, 2026, Medscape published a clinical review examining whether the phenomenon nicknamed Ozempic face is changing how aesthetic medicine is practiced
Taken together, the current clinical evidence suggests that tirzepatide is safe for long-term use in appropriate candidates, particularly under medical supervision with routine monitoring
Morbi leo risus, porta ac consectetur ac, vestibulum at eros
UK pharmacy and clinical practice, guided by the Specialist Pharmacy Service (SPS), generally discourages the routine use of multi-dose vials and requires that any in-use shelf life and storage conditions follow validated, product-specific data
This is an ideal dose and unlikely to produce any potential side effects